Research Article
Invasive Pneumococcal Disease: Still Lots to Learn and a Need for Standardized Data Collection Instruments
Table 3
Comorbid illnesses in 2435 patients with invasive pneumococcal disease.
| | Number | Percent |
| Any underlying disease | 2409 | 98.9 | Selected underlying diseases | | | Epilepsy | 136 | 5.6 | Alzheimer’s disease | 83 | 3.4 | Stroke | 106 | 4.4 | Hypertension | 622 | 25.5 | Heart failure | 156 | 6.4 | Previous myocardial infarction | 168 | 6.9 | Atrial fibrillation | 128 | 5.3 | Anemia | 167 | 6.9 | Insulin dependent diabetes mellitus | 87 | 3.6 | Hepatitis C | 307 | 12.6 | Cirrhosis | 151 | 6.2 | HIV/AIDS | 117 | 4.8 | Asplenia | 37 | 1.5 | Rheumatoid arthritis | 56 | 2.3 | Asthma | 266 | 10.9 | Chronic obstructive pulmonary disease | 441 | 18.6 | Cancer within thepast 5 years | 307 | 12.6 | Lung cancer | 53 | 2.1 | Multiple myeloma | 42 | 1.7 | Chronic lymphocytic leukemia | 19 | 0.7 | Lymphoma | 17 | 0.7 | Acute leukemia | 5 | 0.2 | Solid organ transplant | 14 | 0.6 | No underlying disease | 26 | 1.1 | One underlying disease | 2121 | 87.1 | Two underlying diseases | 256 | 10.5 | Three underlying diseases | 32 | 1.3 |
|
|